Comparative Effectiveness of Ticagrelor, Prasugrel, and Clopidogrel for Secondary Prophylaxis in Acute Coronary Syndrome: A Propensity Score‐Matched Cohort Study

Comparative effectiveness evaluation of newer P2Y12 inhibitors (prasugrel and ticagrelor) compared with clopidogrel after acute coronary syndrome (ACS) is limited in real‐world US populations. The objective of this study was to evaluate cardiovascular events based on ticagrelor, prasugrel, and clopi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Arun, Lutsey, Pamela L., St Peter, Wendy L., Schommer, Jon C., Van't Hof, Jeremy R., Rajpurohit, Abhijeet, Farley, Joel F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877194/
https://www.ncbi.nlm.nih.gov/pubmed/36399019
http://dx.doi.org/10.1002/cpt.2797

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877194/
https://www.ncbi.nlm.nih.gov/pubmed/36399019
http://dx.doi.org/10.1002/cpt.2797

Ejemplares similares